Glaxo Settles Cancer Treatment IP Skirmish With Genentech
GlaxoSmithKline has settled a suit with Genentech Inc. and nonprofit cancer treatment center City of Hope over two patents that relate to blood cancer treatment, Glaxo partner Genmab A/S said Tuesday....To view the full article, register now.
Already a subscriber? Click here to view full article